These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27283504)

  • 21. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
    Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
    Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
    Kobayashi T; Aikata H; Hatooka M; Morio K; Morio R; Kan H; Fujino H; Fukuhara T; Masaki K; Ohno A; Naeshiro N; Nakahara T; Honda Y; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Hyogo H; Takahashi S; Chayama K
    Eur Radiol; 2015 Nov; 25(11):3272-81. PubMed ID: 26037713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma.
    Ishikawa A; Fukao K; Tsuji K; Osada A; Yamamoto Y; Ohtsuka M; Tanaka E
    J Gastroenterol Hepatol; 1993; 8(5):426-32. PubMed ID: 8218989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
    Geisel D; Raabe P; Lüdemann L; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T
    Eur Radiol; 2017 Jul; 27(7):3080-3087. PubMed ID: 27966044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC.
    Yoon JH; Choi JI; Jeong YY; Schenk A; Chen L; Laue H; Kim SY; Lee JM
    J Hepatol; 2016 Dec; 65(6):1155-1162. PubMed ID: 27476767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with
    Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y
    Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of hypovascular lesions on dynamic computed tomography and/or gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Gyoda Y; Imamura H; Ichida H; Yoshimoto J; Ishizaki Y; Kuwatsuru R; Kawasaki S
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1242-1248. PubMed ID: 30345571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.
    Shirabe K; Shimada M; Gion T; Hasegawa H; Takenaka K; Utsunomiya T; Sugimachi K
    J Am Coll Surg; 1999 Mar; 188(3):304-9. PubMed ID: 10065820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.
    Sugimori K; Numata K; Okada M; Nihonmatsu H; Takebayashi S; Maeda S; Nakano M; Tanaka K
    J Med Ultrason (2001); 2017 Jan; 44(1):89-100. PubMed ID: 27771842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion.
    Barth BK; Fischer MA; Kambakamba P; Lesurtel M; Reiner CS
    Eur J Radiol; 2016 Apr; 85(4):843-9. PubMed ID: 26971433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
    Eur J Radiol; 2012 Nov; 81(11):3002-9. PubMed ID: 22748558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection.
    Matsuda M; Ichikawa T; Amemiya H; Maki A; Watanabe M; Kawaida H; Kono H; Sano K; Motosugi U; Fujii H
    HPB Surg; 2014; 2014():641685. PubMed ID: 24701029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
    Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H
    Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
    Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.
    Getzin T; Gueler F; Hartleben B; Gutberlet M; Thorenz A; Chen R; Meier M; Bräsen JH; Derlin T; Hartung D; Lang HAS; Haller H; Wacker F; Rong S; Hueper K
    Eur Radiol; 2018 Oct; 28(10):4455-4464. PubMed ID: 29713782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.